{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T09:59:08Z","timestamp":1792058348830,"version":"4.4.0"},"reference-count":284,"publisher":"The Endocrine Society","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2005,8,1]]},"DOI":"10.1210\/er.2004-0002","type":"journal-article","created":{"date-parts":[[2005,7,29]],"date-time":"2005-07-29T20:52:49Z","timestamp":1122670369000},"page":"662-687","source":"Crossref","is-referenced-by-count":728,"title":["Noncalcemic Actions of Vitamin D Receptor Ligands"],"prefix":"10.1210","volume":"26","author":[{"given":"Sunil","family":"Nagpal","sequence":"first","affiliation":[{"name":"Lilly Research Laboratories, Eli Lilly and Company, Lilly Corporate Center, Indianapolis, Indiana 46285"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Songqing","family":"Na","sequence":"additional","affiliation":[{"name":"Lilly Research Laboratories, Eli Lilly and Company, Lilly Corporate Center, Indianapolis, Indiana 46285"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Radhakrishnan","family":"Rathnachalam","sequence":"additional","affiliation":[{"name":"Lilly Research Laboratories, Eli Lilly and Company, Lilly Corporate Center, Indianapolis, Indiana 46285"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","published-online":{"date-parts":[[2005,3,29]]},"reference":[{"key":"2019041122082637800_R1","doi-asserted-by":"crossref","first-page":"193","DOI":"10.2174\/1389557033488204","article-title":"Vitamin D receptor as a drug discovery target.","volume":"3","author":"Pinette","year":"2003","journal-title":"Mini Rev Med Chem"},{"key":"2019041122082637800_R2","doi-asserted-by":"crossref","first-page":"961","DOI":"10.2174\/1381612003400128","article-title":"Recent developments in vitamin D analogs.","volume":"6","author":"Fogh","year":"2000","journal-title":"Curr Pharm Des"},{"key":"2019041122082637800_R3","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1185\/03007999809113361","article-title":"Current experience with tacalcitol ointment in the treatment of psoriasis.","volume":"14","author":"Gollnick","year":"1998","journal-title":"Curr Med Res Opin"},{"key":"2019041122082637800_R4","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1111\/j.1600-0773.1995.tb01020.x","article-title":"Calcipotriol: a new drug for topical psoriasis treatment.","volume":"77","author":"Kragballe","year":"1995","journal-title":"Pharmacol Toxicol"},{"key":"2019041122082637800_R5","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1159\/000046993","article-title":"Vitamin D analogs for the treatment of secondary hyperparathyroidism.","volume":"20","author":"Slatopolsky","year":"2002","journal-title":"Blood Purif"},{"key":"2019041122082637800_R6","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1007\/s00223001118","article-title":"Bone mass and markers of bone and calcium metabolism in postmenopausal women treated with 1,25-dihydroxyvitamin D (Calcitriol) for four years.","volume":"67","author":"Sairanen","year":"2000","journal-title":"Calcif Tissue Int"},{"key":"2019041122082637800_R7","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1007\/s00198-003-1570-5","article-title":"Efficacy of \u03b1-calcidol and calcitriol in primary and corticosteroid-induced osteoporosis: a meta-analysis of their effects on bone mineral density and fracture rate.","volume":"15","author":"Richy","year":"2004","journal-title":"Osteoporos Int"},{"key":"2019041122082637800_R8","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1210\/me.2002-0363","article-title":"Vitamin D: more than a \u201cbone-a-fide\u201d hormone.","volume":"17","author":"Sutton","year":"2003","journal-title":"Mol Endocrinol"},{"key":"2019041122082637800_R9","doi-asserted-by":"crossref","first-page":"2385","DOI":"10.1083\/jcb.111.6.2385","article-title":"Immunocytology with microwave-fixed fibroblasts shows 1 \u03b1,25-dihydroxyvitamin D3-dependent rapid and estrogen-dependent slow reorganization of vitamin D receptors.","volume":"111","author":"Barsony","year":"1990","journal-title":"J Cell Biol"},{"key":"2019041122082637800_R10","doi-asserted-by":"crossref","first-page":"3329","DOI":"10.1128\/MCB.14.5.3329","article-title":"Ligand modulates the conversion of DNA-bound vitamin D3 receptor (VDR) homodimers into VDR-retinoid X receptor heterodimers.","volume":"14","author":"Cheskis","year":"1994","journal-title":"Mol Cell Biol"},{"key":"2019041122082637800_R11","doi-asserted-by":"crossref","first-page":"41114","DOI":"10.1074\/jbc.M003791200","article-title":"Dimerization with retinoid X receptor promotes nuclear localization and subnuclear targeting of vitamin D receptor.","volume":"275","author":"Prufer","year":"2000","journal-title":"J Biol Chem"},{"key":"2019041122082637800_R12","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1016\/S0006-291X(02)02742-0","article-title":"Liganded VDR induces CYP3A4 in small intestinal and colon cancer cells via DR3 and ER6 vitamin D responsive elements.","volume":"299","author":"Thompson","year":"2002","journal-title":"Biochem Biophys Res Commun"},{"key":"2019041122082637800_R13","doi-asserted-by":"crossref","first-page":"10529","DOI":"10.1073\/pnas.95.18.10529","article-title":"Multiple promoters direct the tissue-specific expression of novel N-terminal variant human vitamin D receptor gene transcripts.","volume":"95","author":"Crofts","year":"1998","journal-title":"Proc Natl Acad Sci USA"},{"key":"2019041122082637800_R14","doi-asserted-by":"crossref","first-page":"49378","DOI":"10.1074\/jbc.M308448200","article-title":"Direct transcriptional regulation of RelB by 1\u03b1,25-dihydroxyvitamin D3 and its analogs: physiologic and therapeutic implications for dendritic cell function.","volume":"278","author":"Dong","year":"2003","journal-title":"J Biol Chem"},{"key":"2019041122082637800_R15","first-page":"206","article-title":"Characterization of a response element in the 5\u2032-flanking region of the avian (chicken) PTH gene that mediates negative regulation of gene transcription by 1,25-dihydroxyvitamin D3 and binds the vitamin D3 receptor.","volume":"10","author":"Liu","year":"1996","journal-title":"Mol Endocrinol"},{"key":"2019041122082637800_R16","doi-asserted-by":"crossref","first-page":"5789","DOI":"10.1128\/MCB.15.10.5789","article-title":"Transcriptional repression of the interleukin-2 gene by vitamin D3: direct inhibition of NFATp\/AP-1 complex formation by a nuclear hormone receptor.","volume":"15","author":"Alroy","year":"1995","journal-title":"Mol Cell Biol"},{"key":"2019041122082637800_R17","doi-asserted-by":"crossref","first-page":"209","DOI":"10.4049\/jimmunol.160.1.209","article-title":"Nuclear factor of activated T cells (NFAT) as a molecular target for 1\u03b1,25-dihydroxyvitamin D3-mediated effects.","volume":"160","author":"Takeuchi","year":"1998","journal-title":"J Immunol"},{"key":"2019041122082637800_R18","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1111\/j.1432-1033.1997.00063.x","article-title":"1\u03b1,25-dihydroxyvitamin D3 and a variety of its natural metabolites transcriptionally repress nuclear-factor-\u03baB-mediated interleukin-8 gene expression.","volume":"250","author":"Harant","year":"1997","journal-title":"Eur J Biochem"},{"key":"2019041122082637800_R19","doi-asserted-by":"crossref","first-page":"4455","DOI":"10.1073\/pnas.86.12.4455","article-title":"Sequence elements in the human osteocalcin gene confer basal and inducible response to hormonal vitamin D3.","volume":"86","author":"Kerner","year":"1989","journal-title":"Proc Natl Acad Sci USA"},{"key":"2019041122082637800_R20","doi-asserted-by":"crossref","first-page":"4688","DOI":"10.1073\/pnas.89.10.4688","article-title":"1\u03b1,25-dihydroxyvitamin D3 regulates the transcription of carbonic anhydrase II mRNA in avian myelomonocytes.","volume":"89","author":"Lomri","year":"1992","journal-title":"Proc Natl Acad Sci USA"},{"key":"2019041122082637800_R21","doi-asserted-by":"crossref","first-page":"9995","DOI":"10.1073\/pnas.87.24.9995","article-title":"Identification of a DNA sequence responsible for binding of the 1,25-dihydroxyvitamin D3 receptor and 1,25-dihydroxyvitamin D3 enhancement of mouse secreted phosphoprotein 1 (Spp-1 or osteoponstin) gene expression.","volume":"87","author":"Noda","year":"1990","journal-title":"Proc Natl Acad Sci USA"},{"key":"2019041122082637800_R22","doi-asserted-by":"crossref","first-page":"10638","DOI":"10.1074\/jbc.273.17.10638","article-title":"Identification of a vitamin D response element in the proximal promoter of the chicken carbonic anhydrase II gene.","volume":"273","author":"Quelo","year":"1998","journal-title":"J Biol Chem"},{"key":"2019041122082637800_R23","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1006\/bbrc.2001.6251","article-title":"Vitamin D3 augments osteoclastogenesis via vitamin D-responsive element of mouse RANKL gene promoter.","volume":"290","author":"Kitazawa","year":"2002","journal-title":"Biochem Biophys Res Commun"},{"key":"2019041122082637800_R24","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1002\/jcb.10567","article-title":"Vitamin D3 supports osteoclastogenesis via functional vitamin D response element of human RANKL gene promoter.","volume":"89","author":"Kitazawa","year":"2003","journal-title":"J Cell Biochem"},{"key":"2019041122082637800_R25","doi-asserted-by":"crossref","first-page":"27371","DOI":"10.1016\/S0021-9258(19)74259-8","article-title":"Cloning of the promoter for the avian integrin \u03b2 3 subunit gene and its regulation by 1,25-dihydroxyvitamin D3.","volume":"268","author":"Cao","year":"1993","journal-title":"J Biol Chem"},{"key":"2019041122082637800_R26","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1073\/pnas.89.2.603","article-title":"Identification of a 1,25-dihydroxyvitamin D3-response element in the 5\u2032-flanking region of the rat calbindin D-9k gene.","volume":"89","author":"Darwish","year":"1992","journal-title":"Proc Natl Acad Sci USA"},{"key":"2019041122082637800_R27","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1093\/jn\/129.2.581S","article-title":"Transcriptional targets of the vitamin D3 receptor\u2013mediating cell cycle arrest and differentiation.","volume":"129","author":"Freedman","year":"1999","journal-title":"J Nutr"},{"key":"2019041122082637800_R28","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1101\/gad.10.2.142","article-title":"Transcriptional activation of the Cdk inhibitor p21 by vitamin D3 leads to the induced differentiation of the myelomonocytic cell line U937.","volume":"10","author":"Liu","year":"1996","journal-title":"Genes Dev"},{"key":"2019041122082637800_R29","doi-asserted-by":"crossref","first-page":"10545","DOI":"10.1016\/S0021-9258(17)34094-2","article-title":"Identification of a vitamin D-responsive element in the 5\u2032-flanking region of the rat 25-hydroxyvitamin D3 24-hydroxylase gene.","volume":"269","author":"Ohyama","year":"1994","journal-title":"J Biol Chem"},{"key":"2019041122082637800_R30","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1002\/jcb.10339","article-title":"Vitamin D regulated keratinocyte differentiation: role of coactivators.","volume":"88","author":"Bikle","year":"2003","journal-title":"J Cell Biochem"},{"key":"2019041122082637800_R31","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1126\/science.1070477","article-title":"Vitamin D receptor as an intestinal bile acid receptor.","volume":"296","author":"Makishima","year":"2002","journal-title":"Science"},{"key":"2019041122082637800_R32","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1210\/me.2003-0344","article-title":"Identification of a functional vitamin D response element in the human insulin-like growth factor binding protein-3 promoter.","volume":"18","author":"Peng","year":"2004","journal-title":"Mol Endocrinol"},{"key":"2019041122082637800_R33","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/0303-7207(85)90074-7","article-title":"Interactions of 1,25-dihydroxyvitamin D3 and the immune system.","volume":"43","author":"Manolagas","year":"1985","journal-title":"Mol Cell Endocrinol"},{"key":"2019041122082637800_R34","first-page":"68","article-title":"1,25-Dihydroxyvitamin D3 as a natural regulator of human immune functions.","volume":"1","author":"Muller","year":"1996","journal-title":"J Invest Dermatol Symp Proc"},{"key":"2019041122082637800_R35","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1172\/JCI1050","article-title":"Inhibition of IL-12 production by 1,25-dihydroxyvitamin D3.","volume":"101","author":"D\u2019Ambrosio","year":"1998","journal-title":"J Clin Invest"},{"key":"2019041122082637800_R36","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1172\/JCI113009","article-title":"Granulocyte-macrophage colony-stimulating factor. Sensitive and receptor-mediated regulation by 1,25-dihydroxyvitamin D3 in normal human peripheral blood lymphocytes.","volume":"79","author":"Tobler","year":"1987","journal-title":"J Clin Invest"},{"key":"2019041122082637800_R37","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1111\/j.1365-2133.1990.tb01828.x","article-title":"Growth-inhibitory effects of 1,25-dihydroxyvitamin D3 on normal and psoriatic keratinocytes.","volume":"123","author":"Matsumoto","year":"1990","journal-title":"Br J Dermatol"},{"key":"2019041122082637800_R38","first-page":"78","article-title":"Reduction of epidermal abnormalities and inflammatory changes in psoriatic plaques during treatment with vitamin D3 analogs.","volume":"1","author":"van de Kerkhof","year":"1996","journal-title":"J Invest Dermatol Symp Proc"},{"key":"2019041122082637800_R39","doi-asserted-by":"crossref","first-page":"2864","DOI":"10.1210\/endo-119-6-2864","article-title":"Suppression by 1,25(OH)2D3 of transcription of the pre-proparathyroid hormone gene.","volume":"119","author":"Russell","year":"1986","journal-title":"Endocrinology"},{"key":"2019041122082637800_R40","first-page":"672","article-title":"DNA sequences in the rat parathyroid hormone-related peptide gene responsible for 1,25-dihydroxyvitamin D3-mediated transcriptional repression.","volume":"10","author":"Falzon","year":"1996","journal-title":"Mol Endocrinol"},{"key":"2019041122082637800_R41","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1172\/JCI115094","article-title":"Regulation of parathyroid hormone-like peptide in cultured normal human keratinocytes. Effect of growth factors and 1,25 dihydroxyvitamin D3 on gene expression and secretion.","volume":"87","author":"Kremer","year":"1991","journal-title":"J Clin Invest"},{"key":"2019041122082637800_R42","doi-asserted-by":"crossref","first-page":"8097","DOI":"10.1073\/pnas.89.17.8097","article-title":"Sequences in the human parathyroid hormone gene that bind the 1,25-dihydroxyvitamin D3 receptor and mediate transcriptional repression in response to 1,25-dihydroxyvitamin D3.","volume":"89","author":"Demay","year":"1992","journal-title":"Proc Natl Acad Sci USA"},{"key":"2019041122082637800_R43","doi-asserted-by":"crossref","first-page":"10901","DOI":"10.1074\/jbc.273.18.10901","article-title":"A negative vitamin D response DNA element in the human parathyroid hormone-related peptide gene binds to vitamin D receptor along with Ku antigen to mediate negative gene regulation by vitamin D.","volume":"273","author":"Nishishita","year":"1998","journal-title":"J Biol Chem"},{"key":"2019041122082637800_R44","doi-asserted-by":"crossref","first-page":"10338","DOI":"10.1074\/jbc.273.17.10338","article-title":"Granulocyte-macrophage colony-stimulating factor gene transcription is directly repressed by the vitamin D3 receptor. Implication for allosteric influences on nuclear receptor structure and function by a DNA element.","volume":"273","author":"Towers","year":"1998","journal-title":"J Biol Chem"},{"key":"2019041122082637800_R45","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S1043-2760(01)00527-6","article-title":"Nuclear receptor coregulators: multiple modes of modification.","volume":"13","author":"Hermanson","year":"2002","journal-title":"Trends Endocrinol Metabol"},{"key":"2019041122082637800_R46","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1038\/374091a0","article-title":"Interaction of thyroid-hormone receptor with a conserved transcriptional mediator.","volume":"374","author":"Lee","year":"1995","journal-title":"Nature"},{"key":"2019041122082637800_R47","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1002\/(SICI)1097-4644(19981201)71:3<429::AID-JCB11>3.0.CO;2-P","article-title":"Proteasome-mediated degradation of the vitamin D receptor (VDR) and a putative role for SUG1 interaction with the AF-2 domain of VDR.","volume":"71","author":"Masuyama","year":"1998","journal-title":"J Cell Biochem"},{"key":"2019041122082637800_R48","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1002\/(SICI)1097-4644(20000315)76:4<548::AID-JCB3>3.0.CO;2-0","article-title":"Mechanism of action of superactive vitamin D analogs through regulated receptor degradation.","volume":"76","author":"Jaaskelainen","year":"2000","journal-title":"J Cell Biochem"},{"key":"2019041122082637800_R49","doi-asserted-by":"crossref","first-page":"7122","DOI":"10.1074\/jbc.272.11.7122","article-title":"Sug1, a putative transcriptional mediator and subunit of the PA700 proteasome complex, is a DNA helicase.","volume":"272","author":"Fraser","year":"1997","journal-title":"J Biol Chem"},{"key":"2019041122082637800_R50","doi-asserted-by":"crossref","first-page":"40614","DOI":"10.1074\/jbc.M106263200","article-title":"Ternary complexes and cooperative interplay between NCoA-62\/Ski-interacting protein and steroid receptor coactivators in vitamin D receptor-mediated transcription.","volume":"276","author":"Zhang","year":"2001","journal-title":"J Biol Chem"},{"key":"2019041122082637800_R51","doi-asserted-by":"crossref","first-page":"8224","DOI":"10.1074\/jbc.C200712200","article-title":"Interactions of SKIP\/NCoA-62, TFIIB and retinoid X receptor with vitamin D receptor helix H10 residues.","volume":"278","author":"Barry","year":"2003","journal-title":"J Biol Chem"},{"key":"2019041122082637800_R52","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1101\/gad.11.11.1381","article-title":"Human TAF(II)135 potentiates transcriptional activation by the AF-2s of the retinoic acid, vitamin D3, and thyroid hormone receptors in mammalian cells.","volume":"11","author":"Mengus","year":"1997","journal-title":"Genes Dev"},{"key":"2019041122082637800_R53","doi-asserted-by":"crossref","first-page":"5486","DOI":"10.1128\/MCB.19.8.5486","article-title":"Human TAF(II)55 interacts with the vitamin D(3) and thyroid hormone receptors and with derivatives of the retinoid X receptor that have altered transactivation properties.","volume":"19","author":"Lavigne","year":"1999","journal-title":"Mol Cell Biol"},{"key":"2019041122082637800_R54","doi-asserted-by":"crossref","first-page":"10064","DOI":"10.1074\/jbc.275.14.10064","article-title":"The human transcription factor IID subunit human TATA-binding protein-associated factor 28 interacts in a ligand-reversible manner with the vitamin D(3) and thyroid hormone receptors.","volume":"275","author":"Mengus","year":"2000","journal-title":"J Biol Chem"},{"key":"2019041122082637800_R55","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1101\/gad.12.12.1787","article-title":"A novel protein complex that interacts with the vitamin D3 receptor in a ligand-dependent manner and enhances VDR transactivation in a cell-free system.","volume":"12","author":"Rachez","year":"1998","journal-title":"Genes Dev"},{"key":"2019041122082637800_R56","doi-asserted-by":"crossref","first-page":"2718","DOI":"10.1128\/MCB.20.8.2718-2726.2000","article-title":"The DRIP complex and SRC-1\/p160 coactivators share similar nuclear receptor binding determinants but constitute functionally distinct complexes.","volume":"20","author":"Rachez","year":"2000","journal-title":"Mol Cell Biol"},{"key":"2019041122082637800_R57","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1128\/MCB.21.5.1747-1758.2001","article-title":"Determinants of CoRNR-dependent repression complex assembly on nuclear hormone receptors.","volume":"21","author":"Hu","year":"2001","journal-title":"Mol Cell Biol"},{"key":"2019041122082637800_R58","doi-asserted-by":"crossref","first-page":"1976","DOI":"10.1210\/mend.14.12.0566","article-title":"The nuclear receptor corepressor (N-CoR) contains three isoleucine motifs (I\/LXXII) that serve as receptor interaction domains (IDs).","volume":"14","author":"Webb","year":"2000","journal-title":"Mol Endocrinol"},{"key":"2019041122082637800_R59","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1046\/j.1432-1327.2001.01953.x","article-title":"Functional and structural characterization of the insertion region in the ligand binding domain of the vitamin D nuclear receptor.","volume":"268","author":"Rochel","year":"2001","journal-title":"Eur J Biochem"},{"key":"2019041122082637800_R60","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S1097-2765(00)80413-X","article-title":"The crystal structure of the nuclear receptor for vitamin D bound to its natural ligand.","volume":"5","author":"Rochel","year":"2000","journal-title":"Mol Cell"},{"key":"2019041122082637800_R61","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1038\/375377a0","article-title":"Crystal structure of the ligand-binding domain of the human nuclear receptor RXR-\u03b1.","volume":"375","author":"Bourguet","year":"1995","journal-title":"Nature"},{"key":"2019041122082637800_R62","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1038\/nsb0196-87","article-title":"A canonical structure for the ligand-binding domain of nuclear receptors.","volume":"3","author":"Wurtz","year":"1996","journal-title":"Nat Struct Biol"},{"key":"2019041122082637800_R63","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1038\/378681a0","article-title":"Crystal structure of the RAR-\u03b3 ligand-binding domain bound to all-trans retinoic acid.","volume":"378","author":"Renaud","year":"1995","journal-title":"Nature"},{"key":"2019041122082637800_R64","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S0303-7207(98)00077-X","article-title":"Characterization of the activation function-2 domain of the human 1,25-dihydroxyvitamin D3 receptor.","volume":"139","author":"Nakajima","year":"1998","journal-title":"Mol Cell Endocrinol"},{"key":"2019041122082637800_R65","doi-asserted-by":"crossref","first-page":"12876","DOI":"10.1073\/pnas.0403606101","article-title":"Identification of an alternative ligand-binding pocket in the nuclear vitamin D receptor and its functional importance in 1\u03b1,25(OH)2-vitamin D3 signaling.","volume":"101","author":"Mizwicki","year":"2004","journal-title":"Proc Natl Acad Sci USA"},{"key":"2019041122082637800_R66","first-page":"106","article-title":"A second binding site for hydroxytamoxifene within the ligand-binding domain of estrogen receptor \u03b2","author":"Wang","year":"2003"},{"key":"2019041122082637800_R67","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1038\/ng0897-391","article-title":"Mice lacking the vitamin D receptor exhibit impaired bone formation, uterine hypoplasia and growth retardation after weaning.","volume":"16","author":"Yoshizawa","year":"1997","journal-title":"Nat Genet"},{"key":"2019041122082637800_R68","doi-asserted-by":"crossref","first-page":"9831","DOI":"10.1073\/pnas.94.18.9831","article-title":"Targeted ablation of the vitamin D receptor: an animal model of vitamin D-dependent rickets type II with alopecia.","volume":"94","author":"Li","year":"1997","journal-title":"Proc Natl Acad Sci USA"},{"key":"2019041122082637800_R69","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/S0960-0760(99)00042-4","article-title":"In vivo function of VDR in gene expression-VDR knock-out mice.","volume":"69","author":"Kato","year":"1999","journal-title":"J Steroid Biochem Mol Biol"},{"key":"2019041122082637800_R70","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1096\/fj.02-0424fje","article-title":"Impaired insulin secretory capacity in mice lacking a functional vitamin D receptor.","volume":"17","author":"Zeitz","year":"2003","journal-title":"FASEB J"},{"key":"2019041122082637800_R71","doi-asserted-by":"crossref","first-page":"13324","DOI":"10.1073\/pnas.231474698","article-title":"Duodenal calcium absorption in vitamin D receptor-knockout mice: functional and molecular aspects.","volume":"98","author":"Van Cromphaut","year":"2001","journal-title":"Proc Natl Acad Sci USA"},{"key":"2019041122082637800_R72","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1172\/JCI11676","article-title":"Metabolic and cellular analysis of alopecia in vitamin D receptor knockout mice.","volume":"107","author":"Sakai","year":"2001","journal-title":"J Clin Invest"},{"key":"2019041122082637800_R73","doi-asserted-by":"crossref","first-page":"5386","DOI":"10.1210\/endo.142.12.8650","article-title":"Targeting expression of the human vitamin D receptor to the keratinocytes of vitamin D receptor null mice prevents alopecia.","volume":"142","author":"Chen","year":"2001","journal-title":"Endocrinology"},{"key":"2019041122082637800_R74","doi-asserted-by":"crossref","first-page":"38665","DOI":"10.1074\/jbc.M304886200","article-title":"Physical and functional interaction between the vitamin D receptor and hairless corepressor, two proteins required for hair cycling.","volume":"278","author":"Hsieh","year":"2003","journal-title":"J Biol Chem"},{"key":"2019041122082637800_R75","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1038\/35036595","article-title":"Skin abnormalities generated by temporally controlled RXR\u03b1 mutations in mouse epidermis.","volume":"407","author":"Li","year":"2000","journal-title":"Nature"},{"key":"2019041122082637800_R76","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1210\/endo.141.6.7515","article-title":"Evaluation of keratinocyte proliferation and differentiation in vitamin D receptor knockout mice.","volume":"141","author":"Sakai","year":"2000","journal-title":"Endocrinology"},{"key":"2019041122082637800_R77","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1093\/carcin\/23.12.2103","article-title":"Vitamin D(3) receptor ablation sensitizes skin to chemically induced tumorigenesis.","volume":"23","author":"Zinser","year":"2002","journal-title":"Carcinogenesis"},{"key":"2019041122082637800_R78","doi-asserted-by":"crossref","first-page":"5332","DOI":"10.1210\/endo.142.12.8544","article-title":"Aberrant growth plate development in VDR\/RXR \u03b3 double null mutant mice.","volume":"142","author":"Yagishita","year":"2001","journal-title":"Endocrinology"},{"key":"2019041122082637800_R79","doi-asserted-by":"crossref","first-page":"2579","DOI":"10.1096\/fj.01-0433rev","article-title":"Vitamin D: its role and use in immunology.","volume":"15","author":"DeLuca","year":"2001","journal-title":"FASEB J"},{"key":"2019041122082637800_R80","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/S1471-4914(02)02294-3","article-title":"The coming age of 1,25-dihydroxyvitamin D3 analogs as immunomodulatory agents.","volume":"8","author":"Mathieu","year":"2002","journal-title":"Trends Mol Med"},{"key":"2019041122082637800_R81","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1016\/S1567-5769(02)00049-8","article-title":"Immunomodulatory effects of vitamin D receptor ligands in autoimmune diseases.","volume":"2","author":"Adorini","year":"2002","journal-title":"Int Immunopharmacol"},{"key":"2019041122082637800_R82","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1126\/science.6310748","article-title":"1,25-Dihydroxyvitamin D3 receptors in human leukocyte.","volume":"221","author":"Provvedini","year":"1983","journal-title":"Science"},{"key":"2019041122082637800_R83","first-page":"457","article-title":"Dendritic cells from human tissues express receptors for the immunomodulatory vitamin D3 metabolite, dihydroxycholecalciferol.","volume":"61","author":"Brennan","year":"1987","journal-title":"Immunology"},{"key":"2019041122082637800_R84","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1006\/abbi.1999.1605","article-title":"Expression of 1,25-dihydroxvatamin D3 receptor in the immune system.","volume":"374","author":"Veldman","year":"2000","journal-title":"Arch Biochem Biophys"},{"key":"2019041122082637800_R85","doi-asserted-by":"crossref","first-page":"3225","DOI":"10.1210\/endo.141.9.7666","article-title":"Vitamin D-mediated gene regulation in phenotypically defined B cell subpopulations.","volume":"141","author":"Morgan","year":"2000","journal-title":"Endocrinology"},{"key":"2019041122082637800_R86","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1159\/000233815","article-title":"Effect of corticosteroid and 1,25R-dihydroxy-vitamin D3 administration on lymphoproliferation and autoimmune disease in MRL\/MRL-lpr\/lpr mice.","volume":"77","author":"Koizumi","year":"1985","journal-title":"Int Arch Allergy Appl Immunol"},{"key":"2019041122082637800_R87","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/S0041-1345(97)01398-5","article-title":"Prevention of diabetes recurrence after syngeneic islet transplantation in NOD by 1a,25(OH)2D3 analogues of in combination with cyclosporin A: mechanism of action involves an immune shift from Th1 to Th2.","volume":"30","author":"Mathieu","year":"1998","journal-title":"Transplant Proc"},{"key":"2019041122082637800_R88","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1046\/j.1365-2249.2002.01825.x","article-title":"Treatment of autoimmune diabetes recurrence in non-obese diabetic mice by mouse interferon-\u03b2 in combination with an analogue of 1\u03b1,25-dihydroxyvitamin D3.","volume":"128","author":"Gysemans","year":"2002","journal-title":"Clin Exp Immunol"},{"key":"2019041122082637800_R89","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.2337\/diabetes.49.8.1301","article-title":"1\u03b1,25-dihydroxyvitamin D3 induces an autoantigen-specific T-helper 1\/T-helper 2 immune shift in NOD mice immunized with GAD65 (p524\u2013543).","volume":"49","author":"Overbergh","year":"2000","journal-title":"Diabetes"},{"key":"2019041122082637800_R90","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1002\/(SICI)1099-0895(199603)12:1<57::AID-DMR157>3.0.CO;2-L","article-title":"Vitamin D analogues in insulin-dependent diabetes mellitus and other autoimmune diseases: a therapeutic perspective.","volume":"12","author":"Mauricio","year":"1996","journal-title":"Diabetes Metab Rev"},{"key":"2019041122082637800_R91","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1210\/endo.136.3.7867594","article-title":"Prevention of type I diabetes in NOD mice by nonhypercalcemic doses of a new structural analog of 1,25-dihydroxyvitamin D3, KH1060.","volume":"136","author":"Mathieu","year":"1995","journal-title":"Endocrinology"},{"key":"2019041122082637800_R92","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.2337\/diabetes.51.5.1367","article-title":"A 1\u03b1,25-dihydroxyvitamin D(3) analog enhances regulatory T-cells and arrests autoimmune diabetes in NOD mice.","volume":"51","author":"Gregori","year":"2002","journal-title":"Diabetes"},{"key":"2019041122082637800_R93","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1093\/jn\/128.1.68","article-title":"1,25-dihydroxycholecalciferol inhibits the progression of arthritis in murine models of human arthritis.","volume":"128","author":"Cantorna","year":"1998","journal-title":"J Nutr"},{"key":"2019041122082637800_R94","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1046\/j.1365-2249.1998.00706.x","article-title":"A vitamin D analogue (MC1288) has immunomodulatory properties and suppresses collagen-induced arthritis (CIA) without causing hypercalcaemia.","volume":"114","author":"Larsson","year":"1998","journal-title":"Clin Exp Immunol"},{"key":"2019041122082637800_R95","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/0014-5793(94)80201-7","article-title":"1\u03b1-hydroxyvitamin D3 inhibits type II collagen-induced arthritis in rats.","volume":"337","author":"Tsuji","year":"1994","journal-title":"FEBS Lett"},{"key":"2019041122082637800_R96","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1007\/s00401-002-0663-0","article-title":"Treatment of experimental autoimmune encephalomyelitis in rat by 1,25-dihydroxyvitamin D3 leads to early effects within the central nervous system.","volume":"105","author":"Garcion","year":"2003","journal-title":"Acta Neuropathol"},{"key":"2019041122082637800_R97","doi-asserted-by":"crossref","first-page":"5557","DOI":"10.1073\/pnas.082100699","article-title":"CD8+ T cells are not necessary for 1,25-dihydroxyvitmin D3 to suppress experimental autoimmune encephalomyelitis in mice.","volume":"99","author":"Meehan","year":"2002","journal-title":"Proc Natl Acad Sci USA"},{"key":"2019041122082637800_R98","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/S0165-5728(01)00360-5","article-title":"Rag-1-dependent cells are necessary for 1,25-dihydroxyvitamin D3 prevention of experimental autoimmune encephalomyelitis.","volume":"119","author":"Nashold","year":"2001","journal-title":"J Neuroimmunol"},{"key":"2019041122082637800_R99","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S0165-5728(99)00247-7","article-title":"1,25-dihydroxyvitamin D3 treatment decreases macrophage accumulation in the CNS of mice with experimental autoimmune encephalomyelitis.","volume":"103","author":"Nashold","year":"2000","journal-title":"J Neuroimmunol"},{"key":"2019041122082637800_R100","doi-asserted-by":"crossref","first-page":"5314","DOI":"10.4049\/jimmunol.160.11.5314","article-title":"1,25-dihydroxyvitamin D3 is a positive regulator for the two anti-encephalitogenic cytokines TGF-\u03b2 1 and IL-4.","volume":"160","author":"Cantorna","year":"1998","journal-title":"J Immunol"},{"key":"2019041122082637800_R101","doi-asserted-by":"crossref","first-page":"21","DOI":"10.3181\/00379727-216-44153A","article-title":"Vitamin D and multiple sclerosis.","volume":"216","author":"Hayes","year":"1997","journal-title":"Proc Soc Exp Biol Med"},{"key":"2019041122082637800_R102","doi-asserted-by":"crossref","first-page":"2648","DOI":"10.1093\/jn\/130.11.2648","article-title":"1,25-dihydroxycholecalciferol prevents and ameliorates symptoms of experimental murine inflammatory bowel disease.","volume":"130","author":"Cantorna","year":"2000","journal-title":"J Nutr"},{"key":"2019041122082637800_R103","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/S0092-8674(00)80702-3","article-title":"A novel transcription factor, T-bet, directs Th1 lineage commitment.","volume":"100","author":"Szabo","year":"2000","journal-title":"Cell"},{"key":"2019041122082637800_R104","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1002\/1521-4141(200002)30:2<498::AID-IMMU498>3.0.CO;2-Q","article-title":"Inhibition of Th1 development and treatment of chronic-relapsing experimental allergic encephalomyelitis by a non-hypercalcemic analogue of 1,25-dihydroxyvitamin D(3).","volume":"30","author":"Mattner","year":"2000","journal-title":"Eur J Immunol"},{"key":"2019041122082637800_R105","doi-asserted-by":"crossref","first-page":"7861","DOI":"10.1073\/pnas.93.15.7861","article-title":"1,25-dihydroxyvitmin D3 reversibly blocks the progression of relapsing encephalomyelitis, a model of multiple sclerosis.","volume":"93","author":"Cantorna","year":"1996","journal-title":"Proc Natl Acad Sci USA"},{"key":"2019041122082637800_R106","doi-asserted-by":"crossref","first-page":"4974","DOI":"10.4049\/jimmunol.167.9.4974","article-title":"1,25-dihydroxyvitmin D3 has a direct effect on nai\u0308ve CD4+ T cells to enhance the development of Th2 cells.","volume":"167","author":"Boonstra","year":"1998","journal-title":"J Immunol"},{"key":"2019041122082637800_R107","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S0092-8674(00)81109-5","article-title":"Rheumatoid arthritis.","volume":"85","author":"Feldman","year":"1996","journal-title":"Cell"},{"key":"2019041122082637800_R108","doi-asserted-by":"crossref","first-page":"172","DOI":"10.3109\/03009749309099266","article-title":"Low serum vitamin D metabolites in women with rheumatoid arthritis.","volume":"22","author":"Kroger","year":"1993","journal-title":"Scand J Rheumatol"},{"key":"2019041122082637800_R109","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1002\/art.1780331117","article-title":"Treatment of psoriatic arthritis with oral 1,25-dihydroxyvitamin D3: a pilot study.","volume":"33","author":"Huckins","year":"1990","journal-title":"Arthritis Rheum"},{"key":"2019041122082637800_R110","first-page":"452","article-title":"Disease modifying and immunomodulatory effect of high dose 1\u03b1(OH)2D3 in rheumatoid arthritis patients.","volume":"17","author":"Andjelkovic","year":"1999","journal-title":"Clin Exp Rheumatol"},{"key":"2019041122082637800_R111","first-page":"26","article-title":"Effect of 1, 25-dihydroxyvitamin D3 on induction of chondrocyte maturation in tissue culture: extracellular matrix gene expression and morphology.","volume":"49","author":"Gerstenfeld","year":"1990","journal-title":"Endocrinology"},{"key":"2019041122082637800_R112","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1186\/ar12","article-title":"The effects of 1 \u03b1,25-dihydroxyvitamin D(3) on matrix metalloproteinase and prostaglandin E(2) production by cells of the rheumatoid lesion.","volume":"1","author":"Tetlow","year":"1999","journal-title":"Arthritis Res"},{"key":"2019041122082637800_R113","doi-asserted-by":"crossref","first-page":"3464","DOI":"10.4049\/jimmunol.158.7.3464","article-title":"Analysis of intestinal lymphocyte in mouse colitis mediated by transfer CD4+CD45Rbhi T cell in SCID recipient.","volume":"158","author":"Aranda","year":"1997","journal-title":"J Immunol"},{"key":"2019041122082637800_R114","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1002\/(SICI)1521-4141(199801)28:01<379::AID-IMMU379>3.0.CO;2-X","article-title":"Increased intracellular Th1 cytokine in SCID mice in inflammatory bowel disease.","volume":"28","author":"Bragenholt","year":"1998","journal-title":"Eur J Immunol"},{"key":"2019041122082637800_R115","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/0092-8674(93)80068-P","article-title":"Interleukin-10 deficient mice develop chronic enterocolitis.","volume":"75","author":"Kuhn","year":"1993","journal-title":"Cell"},{"key":"2019041122082637800_R116","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1136\/gut.35.12.1718","article-title":"Calcipotriol inhibits rectal epithelial cell proliferation in ulcerative protocolitis.","volume":"35","author":"Thomas","year":"1994","journal-title":"Gut"},{"key":"2019041122082637800_R117","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/S0006-2952(00)00564-5","article-title":"Suppressive effect of 1,23-dihydroxyvitamin D3 and its anlogues EB1089 and KH1060 on T lymphocyte proliferation in active ulcerative colitis.","volume":"61","author":"Stio","year":"2001","journal-title":"Biochem Pharmacol"},{"key":"2019041122082637800_R118","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0092-8674(00)80174-9","article-title":"Cell death mediations in autoimmune diabetes-no shortage of suspects.","volume":"89","author":"Benoist","year":"1997","journal-title":"Cell"},{"key":"2019041122082637800_R119","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1038\/9442","article-title":"The NOD model of type I diabetes: as good as it gets?","volume":"5","author":"Atkinson","year":"1999","journal-title":"Nat Med"},{"key":"2019041122082637800_R120","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1007\/s00125-004-1329-3","article-title":"Vitamin D deficiency in early life accelerates Type 1 diabetes in non-obese diabetic mice.","volume":"47","author":"Giulietti","year":"2004","journal-title":"Diabetologia"},{"key":"2019041122082637800_R121","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1007\/BF00403372","article-title":"Prevention of autoimmune diabetes in NOD mice by 1,25-dihydroxyvitamin D3.","volume":"37","author":"Mathieu","year":"1994","journal-title":"Diabetologia"},{"key":"2019041122082637800_R122","doi-asserted-by":"crossref","first-page":"21","DOI":"10.3177\/jnsv.36.21","article-title":"Prevention of immunological disorders in MRL\/l mice by a new synthetic analogue of vitamin D3: 22-oxa-1\u03b1,25-dihydroxyvitamin D3.","volume":"36","author":"Abe","year":"1990","journal-title":"J Nutr Sci Vitaminol"},{"key":"2019041122082637800_R123","first-page":"5827","article-title":"1,25-Dihydroxyvitamin D3-regulated expression of genes involved in human T-lymphocyte proliferation and differentiation.","volume":"46","author":"Matsui","year":"1986","journal-title":"Cancer Res"},{"key":"2019041122082637800_R124","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1126\/science.6427926","article-title":"1,25-dihydroxyvitamin D3: a novel immunoregulatory hormone.","volume":"224","author":"Tsoukas","year":"1984","journal-title":"Science"},{"key":"2019041122082637800_R125","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1172\/JCI111557","article-title":"Inhibition of T lymphocyte mitogenesis by 1,25-dihydroxyvitamin D3 (calcitriol).","volume":"74","author":"Rigby","year":"1984","journal-title":"J Clin Invest"},{"key":"2019041122082637800_R126","doi-asserted-by":"crossref","first-page":"2405","DOI":"10.4049\/jimmunol.164.5.2405","article-title":"1 \u03b1,25-Dihydroxyvitamin D3 inhibits differentiation, maturation, activation, and survival of dendritic cells leading to impaired alloreactive T cell activation.","volume":"164","author":"Penna","year":"2000","journal-title":"J Immunol"},{"key":"2019041122082637800_R127","doi-asserted-by":"crossref","first-page":"143","DOI":"10.3109\/08916939209150321","article-title":"1,25-Dihydroxyvitamin D3 attenuates the expression of experimental murine lupus of MRL\/l mice.","volume":"12","author":"Lemire","year":"1992","journal-title":"Autoimmunity"},{"key":"2019041122082637800_R128","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1097\/00007890-199810150-00002","article-title":"Prolongation of allograft survival by 1,25-dihydroxyvitamin D3.","volume":"66","author":"Hullett","year":"1998","journal-title":"Transplantation"},{"key":"2019041122082637800_R129","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1053\/jhep.2001.28705","article-title":"1\u03b1, 25-Dihydroxycholecalciferol reduces rejection and improves survival in rat liver allografts.","volume":"34","author":"Redaelli","year":"2001","journal-title":"Hepatology"},{"key":"2019041122082637800_R130","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.1016\/S0041-1345(01)02007-3","article-title":"Immunomodulatory properties of a 1,25-dihydroxyvitamin D3 analogue combined with IFN\u03b2 in an animal model of syngeneic islet transplantation.","volume":"33","author":"van Etten","year":"2001","journal-title":"Transplant Proc"},{"key":"2019041122082637800_R131","doi-asserted-by":"crossref","first-page":"2365","DOI":"10.1016\/S0041-1345(01)02022-X","article-title":"A combination of KH1060, a vitamin D3 analogue, and cyclosporin prevents early graft failure and prolongs graft survival of xenogeneic islets in nonobese diabetic mice.","volume":"33","author":"Gysemans","year":"2001","journal-title":"Transplant Proc"},{"key":"2019041122082637800_R132","doi-asserted-by":"crossref","first-page":"2998","DOI":"10.1016\/S0041-1345(99)00641-7","article-title":"Immunomodulatory effects of vitamin D analog KH1060 on an experimental skin transplantation model.","volume":"31","author":"Bertolini","year":"1999","journal-title":"Transplant Proc"},{"key":"2019041122082637800_R133","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/0966-3274(93)90062-D","article-title":"Two novel vitamin D analogues, KH 1060 and CB 966, prolong skin allograft survival in mice.","volume":"1","author":"Veyron","year":"1993","journal-title":"Transpl Immunol"},{"key":"2019041122082637800_R134","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1097\/00007890-199704150-00005","article-title":"A vitamin D analog, MC1288, inhibits adventitial inflammation and suppresses intimal lesions in rat aortic allografts.","volume":"63","author":"Raisanen-Sokolowski","year":"1997","journal-title":"Transplantation"},{"key":"2019041122082637800_R135","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1007\/s002239900201","article-title":"Role of alfacalcidiol on bone quality and immunomodulation in autoimmune disease and organ transplantation.","volume":"60","author":"Dequeker","year":"1997","journal-title":"Calcif Tissue Int"},{"key":"2019041122082637800_R136","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1007\/s002239900709","article-title":"Alfacalcidol and calcitriol in the prevention of bone loss after organ transplantation.","volume":"65","author":"Sambrook","year":"1999","journal-title":"Calcif Tissue Int"},{"key":"2019041122082637800_R137","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1097\/01.TP.0000065179.06731.99","article-title":"Reduction of immunosuppressant therapy requirement in heart transplantation by calcitriol.","volume":"75","author":"Briffa","year":"2003","journal-title":"Transplantation"},{"key":"2019041122082637800_R138","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.4049\/jimmunol.133.4.1748","article-title":"1,25-Dihydroxyvitamin D3 inhibits antigen-induced T cell activation.","volume":"133","author":"Bhalla","year":"1984","journal-title":"J Immunol"},{"key":"2019041122082637800_R139","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1172\/JCI113004","article-title":"Regulation of lymphokine production and human T lymphocyte activation by 1,25-dihydroxyvitamin D3. Specific inhibition at the level of messenger RNA.","volume":"79","author":"Rigby","year":"1987","journal-title":"J Clin Invest"},{"key":"2019041122082637800_R140","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1038\/32588","article-title":"Dendritic cells and the control of immunity.","volume":"392","author":"Banchereau","year":"1998","journal-title":"Nature"},{"key":"2019041122082637800_R141","doi-asserted-by":"crossref","first-page":"3821","DOI":"10.4049\/jimmunol.154.8.3821","article-title":"Human blood dendritic cells selectively express CD83, a member of the immunoglobulin superfamily.","volume":"154","author":"Zhou","year":"1995","journal-title":"J Immunol"},{"key":"2019041122082637800_R142","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/S1471-4906(01)01952-4","article-title":"Dendritic cells as a tool to induce anergic and regulatory T cells.","volume":"22","author":"Jonuleit","year":"2001","journal-title":"Trends Immunol"},{"key":"2019041122082637800_R143","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1146\/annurev.immunol.18.1.767","article-title":"Immunobiology of dendritic cells.","volume":"18","author":"Banchereau","year":"2000","journal-title":"Annu Rev Immunol"},{"key":"2019041122082637800_R144","doi-asserted-by":"crossref","first-page":"6800","DOI":"10.1073\/pnas.121172198","article-title":"Dendritic cell modulation by 1\u03b1,25 dihydroxyvitamin D3 and its analogs: a vitamin D receptor-dependent pathway that promotes a persistent state of immaturity in vitro and in vivo.","volume":"98","author":"Griffin","year":"2001","journal-title":"Proc Natl Acad Sci USA"},{"key":"2019041122082637800_R145","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/S0301-472X(00)00143-0","article-title":"1,25-Dihydroxyvitamin D(3) inhibits dendritic cell differentiation and maturation in vitro.","volume":"28","author":"Berer","year":"2000","journal-title":"Exp Hematol"},{"key":"2019041122082637800_R146","doi-asserted-by":"crossref","first-page":"4443","DOI":"10.4049\/jimmunol.164.9.4443","article-title":"Vitamin D3 affects differentiation, maturation, and function of human monocyte-derived dendritic cells.","volume":"164","author":"Piemonti","year":"2000","journal-title":"J Immunol"},{"key":"2019041122082637800_R147","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1002\/jcb.10340","article-title":"Tolerogenic dendritic cells induced by vitamin D receptor ligands enhance regulatory T cells inhibiting allograft rejection and autoimmune diseases.","volume":"88","author":"Adorini","year":"2003","journal-title":"J Cell Biochem"},{"key":"2019041122082637800_R148","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1210\/jcem-51-6-1463","article-title":"Demonstration of 1,25-dihydroxyvitamin D3 receptors in human skin biopsies.","volume":"51","author":"Feldman","year":"1980","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041122082637800_R149","first-page":"51","article-title":"A patient with psoriasis cured by 1 \u03b1-hydroxyvitamin D3.","volume":"35","author":"Morimoto","year":"1985","journal-title":"Med J Osaka Univ"},{"key":"2019041122082637800_R150","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.2174\/0929867013371950","article-title":"Vitamin D analogs: mechanism of action and therapeutic applications.","volume":"8","author":"Nagpal","year":"2001","journal-title":"Curr Med Chem"},{"issue":"Suppl 58","key":"2019041122082637800_R151","first-page":"11","article-title":"Efficacy and tolerance of topical calcitriol 3 microg g(-1) in psoriasis treatment: a review of our experience in Poland","volume":"144","author":"Langner","year":"2001","journal-title":"Br J Dermatol"},{"key":"2019041122082637800_R152","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1080\/09546630305543","article-title":"Calcium homeostasis remains unaffected after 12 weeks\u2019 therapy with calcitriol 3 microg\/g ointment; no correlation with extent of psoriasis.","volume":"14","author":"Barker","year":"2003","journal-title":"J Dermatolog Treat"},{"key":"2019041122082637800_R153","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1159\/000246851","article-title":"Long-term use of topical calcipotriol in chronic plaque psoriasis.","volume":"189","author":"Ramsay","year":"1994","journal-title":"Dermatology"},{"key":"2019041122082637800_R154","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/S1359-6446(99)01335-5","article-title":"Novel approaches for the treatment of psoriasis.","volume":"4","author":"DiSepio","year":"1999","journal-title":"Drug Discov Today"},{"key":"2019041122082637800_R155","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1080\/09546630305545","article-title":"Calcitriol shows greater persistence of treatment effect than betamethasone dipropionate in topical psoriasis therapy.","volume":"14","author":"Camarasa","year":"2003","journal-title":"J Dermatolog Treat"},{"key":"2019041122082637800_R156","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1046\/j.1365-2133.2002.04949.x","article-title":"Molecular basis of the alteration in skin collagen metabolism in response to in vivo dexamethasone treatment: effects on the synthesis of collagen type I and III, collagenase, and tissue inhibitors of metalloproteinases.","volume":"147","author":"Oishi","year":"2002","journal-title":"Br J Dermatol"},{"key":"2019041122082637800_R157","first-page":"261","article-title":"Calcitriol ointment and clobetasol propionate cream: a new regimen for the treatment of plaque psoriasis.","volume":"13","author":"Lahfa","year":"2003","journal-title":"Eur J Dermatol"},{"key":"2019041122082637800_R158","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1067\/mjd.2003.130","article-title":"Early onset of action and efficacy of a combination of calcipotriene and betamethasone dipropionate in the treatment of psoriasis.","volume":"48","author":"Papp","year":"2003","journal-title":"J Am Acad Dermatol"},{"key":"2019041122082637800_R159","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1159\/000066440","article-title":"A new calcipotriol\/betamethasone dipropionate formulation (Daivobet) is an effective once-daily treatment for psoriasis vulgaris.","volume":"205","author":"Kaufmann","year":"2002","journal-title":"Dermatology"},{"key":"2019041122082637800_R160","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0923-1811(02)00136-6","article-title":"Similarly potent action of 1,25-dihydroxyvitamin D3 and its analogues tacalcitol, calcipotriol, and maxacalcitol on normal human keratinocyte proliferation and differentiation.","volume":"31","author":"Takahashi","year":"2003","journal-title":"J Dermatol Sci"},{"key":"2019041122082637800_R161","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1002\/jcp.1041460113","article-title":"Role of intracellular-free calcium in the cornified envelope formation of keratinocytes: differences in the mode of action of extracellular calcium and 1,25 dihydroxyvitamin D3.","volume":"146","author":"Pillai","year":"1991","journal-title":"J Cell Physiol"},{"key":"2019041122082637800_R162","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1002\/(SICI)1097-4652(199902)178:2<188::AID-JCP8>3.0.CO;2-4","article-title":"1,25 Dihydroxyvitamin D3 enhances the calcium response of keratinocytes.","volume":"178","author":"Ratnam","year":"1999","journal-title":"J Cell Physiol"},{"key":"2019041122082637800_R163","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1046\/j.1365-2133.1998.02029.x","article-title":"Calcipotriene-induced improvement in psoriasis is associated with reduced interleukin-8 and increased interleukin-10 levels within lesions.","volume":"138","author":"Kang","year":"1998","journal-title":"Br J Dermatol"},{"key":"2019041122082637800_R164","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1007\/s000110050042","article-title":"1,25-(OH)2-vitamin D3 and calcipotriol induce IL-10 receptor gene expression in human epidermal cells.","volume":"46","author":"Michel","year":"1997","journal-title":"Inflamm Res"},{"key":"2019041122082637800_R165","doi-asserted-by":"crossref","first-page":"154","DOI":"10.3322\/canjclin.52.3.154","article-title":"The current state of hormonal therapy for prostate cancer.","volume":"52","author":"Hellerstedt","year":"2002","journal-title":"CA Cancer J Clin"},{"key":"2019041122082637800_R166","doi-asserted-by":"crossref","first-page":"1952","DOI":"10.1210\/endo.132.5.7682937","article-title":"Vitamin D and prostate cancer: 1,25 dihydroxyvitamin D3 receptors and actions in human prostate cancer cell lines.","volume":"132","author":"Skowronski","year":"1993","journal-title":"Endocrinology"},{"key":"2019041122082637800_R167","author":"Feldman","year":"1995"},{"key":"2019041122082637800_R168","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0960-0760(98)00054-5","article-title":"Localization of 1,25-dihydroxyvitamin D3 receptor (VDR) expression in human prostate.","volume":"66","author":"Kivineva","year":"1998","journal-title":"J Steroid Biochem Mol Biol"},{"key":"2019041122082637800_R169","first-page":"1307","article-title":"Is vitamin D deficiency a risk factor for prostate cancer?","volume":"10","author":"Schwartz","year":"1990","journal-title":"Anticancer Res"},{"key":"2019041122082637800_R170","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1023\/A:1008923802001","article-title":"Prostate cancer risk and prediagnostic serum 25-hydroxyvitamin D levels (Finland).","volume":"11","author":"Ahonen","year":"2000","journal-title":"Cancer Causes Control"},{"key":"2019041122082637800_R171","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S0303-7207(01)00671-2","article-title":"Vitamin D-mediated growth inhibition of an androgen-ablated LNCaP cell line model of human prostate cancer.","volume":"186","author":"Yang","year":"2002","journal-title":"Mol Cell Endocrinol"},{"key":"2019041122082637800_R172","first-page":"805","article-title":"Antiprolifeartive effects of 1,25-dihydroxyvitamin D3 on primary cultures of human prostatic cells.","volume":"54","author":"Peehl","year":"1994","journal-title":"Cancer Res"},{"key":"2019041122082637800_R173","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1002\/jcb.10334","article-title":"Inhibition of prostate cancer growth by vitamin D: regulation of target gene expression.","volume":"88","author":"Krishnan","year":"2003","journal-title":"J Cell Biochem"},{"key":"2019041122082637800_R174","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1016\/S0090-4295(97)00408-1","article-title":"Vitamin D inhibition of prostate adenocarcinoma growth and metastasis in the Dunning rat prostate model system.","volume":"50","author":"Getzenberg","year":"1997","journal-title":"Urology"},{"key":"2019041122082637800_R175","first-page":"241","article-title":"Inhibition of prostate cancer metastasis in vivo: a comparison of 1,25-dihydroxyvitamin D (calcitriol) and EB1089.","volume":"8","author":"Lokeshwar","year":"1999","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"2019041122082637800_R176","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1002\/pros.1138","article-title":"Novel nonsecostroidal vitamin D receptor modulator inhibits the growth of LNCaP xenograft tumors in athymic mice without increased serum calcium.","volume":"49","author":"Polek","year":"2001","journal-title":"Prostate"},{"key":"2019041122082637800_R177","first-page":"283","article-title":"Ability of potent vitamin D3 analogs to inhibit growth of prostate cancer cells in vivo.","volume":"23","author":"Vegesna","year":"2003","journal-title":"Anticancer Res"},{"key":"2019041122082637800_R178","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1002\/pros.2990260203","article-title":"IGF-binding proteins in human prostate tumor cells: expression and regulation by 1,25-dihydroxyvitamin D3.","volume":"26","author":"Drivdahl","year":"1995","journal-title":"Prostate"},{"key":"2019041122082637800_R179","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1677\/jme.0.0190015","article-title":"Inhibition of proliferation of prostate cancer cells by a 19-nor-hexafluoride vitamin D3 analogue involves the induction of p21waf1, p27kip1, and E-cadherin.","volume":"19","author":"Campbell","year":"1997","journal-title":"J Mol Endocrinol"},{"key":"2019041122082637800_R180","first-page":"137","article-title":"Regulation of insulin-like growth factor binding protein 3 autocrine loop in human PC-3 prostate cancer cells by vitamin D metabolite 1,25-(OH)2D3 and its analog EB 1089.","volume":"13","author":"Huynh","year":"1998","journal-title":"Int J Oncol"},{"key":"2019041122082637800_R181","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1016\/S0022-5347(01)69892-6","article-title":"Insulin-like growth factor binding protein-3 mediates 1 \u03b1, 25-dihydroxyvitamin D3 growth inhibition in the LNCaP prostate cancer cell line through p21\/WAF1.","volume":"165","author":"Boyle","year":"2001","journal-title":"J Urol"},{"key":"2019041122082637800_R182","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1210\/endo.140.5.6698","article-title":"Liarozole acts synergistically with 1\u03b1, 25-dihydroxyvitamin D3 to inhibit growth of DU 145 human prostate cancer cells by blocking 24-hydroxylase activity.","volume":"140","author":"Ly","year":"1999","journal-title":"Endocrinology"},{"key":"2019041122082637800_R183","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1016\/S0022-5347(05)64525-9","article-title":"Preclinical activity of ketoconazole in combination with calcitriol or the vitamin D analog EB 1089 on prostate cancer cell.","volume":"168","author":"Peehl","year":"2002","journal-title":"J Urol"},{"key":"2019041122082637800_R184","doi-asserted-by":"crossref","first-page":"3290","DOI":"10.1210\/endo.138.8.5328","article-title":"1\u03b1,25-dihydroxyvitamin D3 actions in LNCaP human prostate cancer cells are androgen-dependent.","volume":"138","author":"Zhao","year":"1997","journal-title":"Endocrinology"},{"key":"2019041122082637800_R185","doi-asserted-by":"crossref","first-page":"2548","DOI":"10.1210\/endo.141.7.7549","article-title":"1\u03b1, 25-dihydroxyvitamin D3 inhibits prostate cancer cell growth by androgen-dependent and androgen-independent mechanisms.","volume":"141","author":"Zhao","year":"2000","journal-title":"Endocrinology"},{"key":"2019041122082637800_R186","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1016\/S0022-5347(01)63236-1","article-title":"Treatment of early recurrent prostate cancer with 1,25-dihydroxyvitamin D3 (calcitriol).","volume":"159","author":"Gross","year":"1998","journal-title":"J Urol"},{"key":"2019041122082637800_R187","first-page":"421","article-title":"Novel vitamin D3 analog (CB1093) when combined with paclitaxel and cisplatin inhibit growth of MCF-7 human breast cancer cells in vivo.","volume":"13","author":"Koshizuka","year":"1998","journal-title":"Int J Oncol"},{"key":"2019041122082637800_R188","first-page":"2040","article-title":"1,25-dihydroxyvitamin D3 and all-trans-retinoic acid sensitizes breast cancer cells to chemotherapy-induced cell death.","volume":"60","author":"Wang","year":"2000","journal-title":"Cancer Res"},{"key":"2019041122082637800_R189","first-page":"1043","article-title":"Calcitriol (1,25-dihydroxycholecalciferol) enhances paclitaxel antitumor activity in vitro and in vivo and accelerates paclitaxel-induced apoptosis.","volume":"7","author":"Hershberger","year":"2001","journal-title":"Clin Cancer Res"},{"key":"2019041122082637800_R190","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1200\/jco.2003.05.117","article-title":"Weekly high-dose calcitriol and docetaxel in metastatic androgen-independent prostate cancer.","volume":"21","author":"Beer","year":"2003","journal-title":"J Clin Oncol"},{"key":"2019041122082637800_R191","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S0303-7207(02)00370-2","article-title":"Des (1\u20133) IGF-I-stimulated growth of human stromal BPH cells is inhibited by a vitamin D3 analogue.","volume":"198","author":"Crescioli","year":"2002","journal-title":"Mol Cell Endocrinol"},{"key":"2019041122082637800_R192","first-page":"2186","article-title":"Expression and cellular localization of keratinocyte growth factor and its receptor in human hyperplastic prostate tissue.","volume":"83","author":"De Bellis","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041122082637800_R193","first-page":"2576","article-title":"Effect of a vitamin D3 analogue on keratinocyte growth factor-induced cell proliferation in benign prostate hyperplasia.","volume":"85","author":"Crescioli","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041122082637800_R194","doi-asserted-by":"crossref","first-page":"3046","DOI":"10.1210\/en.2002-0210","article-title":"Inhibition of spontaneous and androgen-induced prostate growth by a nonhypercalcemic calcitriol analog.","volume":"144","author":"Crescioli","year":"2003","journal-title":"Endocrinology"},{"key":"2019041122082637800_R195","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1007\/s00280-003-0606-z","article-title":"Effect of the vitamin D3 analog ILX 23\u20137553 on apoptosis and sensitivity to fractionated radiation in breast tumor cells and normal human fibroblasts.","volume":"51","author":"Polar","year":"2003","journal-title":"Cancer Chemother Pharmacol"},{"key":"2019041122082637800_R196","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/0091-7435(90)90058-R","article-title":"Geographic variation in breast cancer mortality in the United States: a hypothesis involving exposure to solar radiation.","volume":"19","author":"Garland","year":"1990","journal-title":"Prev Med"},{"key":"2019041122082637800_R197","first-page":"399","article-title":"Vitamin D and breast cancer risk: the NHANES epidemiologic follow-up study, 1971\u20131975 to 1992. National Health and Nutrition Examination Survey.","volume":"8","author":"John","year":"1999","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"2019041122082637800_R198","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1038\/75985","article-title":"Quantitative mapping of amplicon structure by array CGH identifies CYP24 as a candidate oncogene.","volume":"25","author":"Albertson","year":"2000","journal-title":"Nat Genet"},{"key":"2019041122082637800_R199","first-page":"118","article-title":"Serum 1,25-dihydroxyvitamin D may be related inversely to disease activity in breast cancer patients with bone metastases.","volume":"82","author":"Mawer","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041122082637800_R200","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1590\/S0100-879X2002000100001","article-title":"Antiproliferative effects of 1,25-dihydroxyvitamin D3 on breast cells: a mini review.","volume":"35","author":"Bortman","year":"2002","journal-title":"Braz J Med Biol Res"},{"key":"2019041122082637800_R201","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1023\/A:1021343825552","article-title":"Analysis of vitamin D receptor (VDR) and retinoid X receptor \u03b1 in breast cancer.","volume":"34","author":"Friedrich","year":"2002","journal-title":"Histochem J"},{"key":"2019041122082637800_R202","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0960-0760(03)00028-1","article-title":"Efficacy of vitamin D compounds to modulate estrogen receptor negative breast cancer growth and invasion.","volume":"84","author":"Flanagan","year":"2003","journal-title":"J Steroid Biochem Mol Biol"},{"key":"2019041122082637800_R203","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1038\/sj.onc.1201329","article-title":"Modulation of cell cycle control by vitamin D3 and its analogue, EB 1089, in human breast cancer cells.","volume":"15","author":"Wu","year":"1997","journal-title":"Oncogene"},{"key":"2019041122082637800_R204","first-page":"1370","article-title":"Inhibitory effects of 1\u03b1,25-dihydroxyvitamin D3 on the G1-S phase-controlling machinery.","volume":"15","author":"Jensen","year":"2001","journal-title":"Mol Endocrinol"},{"key":"2019041122082637800_R205","doi-asserted-by":"crossref","first-page":"32309","DOI":"10.1074\/jbc.274.45.32309","article-title":"Sp1 and NF-Y synergistically mediate the effect of vitamin D3 in the p27Kip1 gene promoter that lacks vitamin D response elements.","volume":"274","author":"Inoue","year":"1999","journal-title":"J Biol Chem"},{"key":"2019041122082637800_R206","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0303-7207(98)00117-8","article-title":"Action of 1,25(OH)2D3 on the cell cycle genes, cyclin D1, p21 and p27 in MCF-7 cells.","volume":"142","author":"Verlinden","year":"1998","journal-title":"Mol Cell Endocrinol"},{"key":"2019041122082637800_R207","first-page":"1540","article-title":"1,25-Dihydroxyvitamin D3 enhances the expression of transforming growth factor \u03b2 1 and its latent form binding protein in cultured breast carcinoma cells.","volume":"55","author":"Koli","year":"1995","journal-title":"Cancer Res"},{"key":"2019041122082637800_R208","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1097\/00001813-199304000-00012","article-title":"Inhibition of c-myc in breast and ovarian carcinoma cells by 1,25-dihydroxyvitamin D3, retinoic acid and dexamethasone.","volume":"4","author":"Saunders","year":"1993","journal-title":"Anticancer Drugs"},{"key":"2019041122082637800_R209","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1677\/joe.0.1690153","article-title":"Antisense knockout of HOXB4 blocks 1,25-dihydroxyvitamin D3 inhibition of c-myc expression.","volume":"169","author":"Pan","year":"2001","journal-title":"J Endocrinol"},{"key":"2019041122082637800_R210","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1093\/jnci\/89.9.652","article-title":"Antiproliferative action of vitamin D-related compounds and insulin-like growth factor binding protein 5 accumulation.","volume":"89","author":"Rozen","year":"1997","journal-title":"J Natl Cancer Inst"},{"key":"2019041122082637800_R211","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1677\/jme.0.0200157","article-title":"Growth inhibition of both MCF-7 and Hs578T human breast cancer cell lines by vitamin D analogues is associated with increased expression of insulin-like growth factor binding protein-3.","volume":"20","author":"Colston","year":"1998","journal-title":"J Mol Endocrinol"},{"key":"2019041122082637800_R212","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/BF01753887","article-title":"1\u03b1,25-Dihydroxyvitamin D3 inhibits the invasive potential of human breast cancer cells in vitro.","volume":"12","author":"Hansen","year":"1994","journal-title":"Clin Exp Metastasis"},{"key":"2019041122082637800_R213","first-page":"4412","article-title":"The vitamin D analogue EB 1089 prevents skeletal metastasis and prolongs survival time in nude mice transplanted with human breast cancer cells.","volume":"60","author":"El Abdaimi","year":"2000","journal-title":"Cancer Res"},{"key":"2019041122082637800_R214","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1161\/01.RES.87.3.214","article-title":"1\u03b1, 25-Dihydroxyvitamin D3 inhibits angiogenesis in vitro and in vivo.","volume":"87","author":"Mantell","year":"2000","journal-title":"Circ Res"},{"key":"2019041122082637800_R215","doi-asserted-by":"crossref","first-page":"479","DOI":"10.2307\/3580143","article-title":"The vitamin D3 analog EB 1089 enhances the response of human breast tumor cells to radiation.","volume":"152","author":"Sundaram","year":"1999","journal-title":"Radiat Res"},{"key":"2019041122082637800_R216","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1023\/A:1006420708806","article-title":"EB 1089 enhances the antiproliferative and apoptotic effects of adriamycin in MCF-7 breast tumor cells to radiation.","volume":"63","author":"Sundaram","year":"2000","journal-title":"Breast Cancer Res Treat"},{"key":"2019041122082637800_R217","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1007\/s002800000251","article-title":"The vitamin D analog ILX-23\u20137553 enhances the response to adriamycin and radiation in MCF-7 breast tumor cells.","volume":"47","author":"Chaudhry","year":"2001","journal-title":"Cancer Chemother Pharmacol"},{"key":"2019041122082637800_R218","first-page":"253","article-title":"Chemoprevention of mammary carcinogenesis by 1\u03b1-hydroxyvitamin D5, a synthetic analog of vitamin D","volume":"523\u2013524","author":"Mehta","year":"2002","journal-title":"Mutat Res"},{"key":"2019041122082637800_R219","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/0304-3835(94)90181-3","article-title":"1,25-Dihydroxyvitamin D3 receptors in normal and malignant human colorectal tissues.","volume":"86","author":"Vandewalle","year":"1994","journal-title":"Cancer Lett"},{"key":"2019041122082637800_R220","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1093\/carcin\/22.9.1429","article-title":"Characterization of a vitamin D receptor knockout mouse as a model of colorectal hyperproliferation and DNA damage.","volume":"22","author":"Kallay","year":"2001","journal-title":"Carcinogenesis"},{"key":"2019041122082637800_R221","doi-asserted-by":"crossref","first-page":"24847","DOI":"10.1074\/jbc.C200187200","article-title":"A vitamin D receptor-Ser\/Thr phosphatase-p70 S6 kinase complex and modulation of its enzymatic activities by the ligand.","volume":"277","author":"Bettoun","year":"2002","journal-title":"J Biol Chem"},{"key":"2019041122082637800_R222","first-page":"979","article-title":"Novel 19-nor-hexafluoride vitamin D3 analog (Ro 25-6760) inhibits human colon cancer in vitro via apoptosis.","volume":"14","author":"Evans","year":"1999","journal-title":"Int J Oncol"},{"key":"2019041122082637800_R223","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1083\/jcb.200102028","article-title":"Vitamin D3 promotes the differentiation of colon carcinoma cells by the induction of E-cadherin and the inhibition of \u03b2-catenin signaling.","volume":"154","author":"Palmer","year":"2001","journal-title":"J Cell Biol"},{"key":"2019041122082637800_R224","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.1210\/endo.132.4.8384998","article-title":"Regulation of vitamin D receptor abundance and responsiveness during differentiation of HT-29 human colon cancer cells.","volume":"132","author":"Zhao","year":"1993","journal-title":"Endocrinology"},{"key":"2019041122082637800_R225","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1093\/jn\/131.6.1839","article-title":"Tributyrin, a stable and rapidly absorbed prodrug of butyric acid, enhances antiproliferative effects of dihydroxycholecalciferol in human colon cancer cells.","volume":"131","author":"Gaschott","year":"2001","journal-title":"J Nutr"},{"key":"2019041122082637800_R226","first-page":"2304","article-title":"Apoptosis is induced by the active metabolite of vitamin D3 and its analogue EB1089 in colorectal adenoma and carcinoma cells: possible implications for prevention and therapy.","volume":"60","author":"Diaz","year":"2000","journal-title":"Cancer Res"},{"key":"2019041122082637800_R227","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1006\/bbrc.2001.6213","article-title":"ZK 156718, a low calcemic, antiproliferative, and prodifferentiating vitamin D analog.","volume":"290","author":"Gaschott","year":"2002","journal-title":"Biochem Biophys Res Commun"},{"key":"2019041122082637800_R228","first-page":"450","article-title":"Biological effects of 1\u03b1-hydroxy- and 1\u03b2-(hydroxymethyl)-vitamin D compounds relevant for potential colorectal cancer therapy.","volume":"291","author":"Hofer","year":"1999","journal-title":"J Pharmacol Exp Ther"},{"key":"2019041122082637800_R229","first-page":"7799","article-title":"Genetic signatures of differentiation induced by 1\u03b1,25-dihydroxyvitamin D3 in human colon cancer cells.","volume":"63","author":"Palmer","year":"2003","journal-title":"Cancer Res"},{"key":"2019041122082637800_R230","first-page":"21","article-title":"Suppression of in vivo growth of human cancer solid tumor xenografts by 1,25-dihydroxyvitamin D3.","volume":"47","author":"Eisman","year":"1987","journal-title":"Cancer Res"},{"key":"2019041122082637800_R231","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1093\/carcin\/13.12.2293","article-title":"A protective role of 1,25-dihydroxyvitamin D3 in chemically induced rat colon carcinogenesis.","volume":"13","author":"Belleli","year":"1992","journal-title":"Carcinogenesis"},{"key":"2019041122082637800_R232","first-page":"3050","article-title":"1 \u03b1,25-Dihydroxy-16-ene-23-yne-26,27-hexafluorocholecalciferol, a noncalcemic analogue of 1 \u03b1,25-dihydroxyvitamin D3, inhibits azoxymethane-induced colonic tumorigenesis.","volume":"55","author":"Wali","year":"1995","journal-title":"Cancer Res"},{"key":"2019041122082637800_R233","first-page":"741","article-title":"1\u03b1,25-(OH)2-D3 and its synthetic analogue decrease tumor load in the Apcmin mouse.","volume":"62","author":"Huerta","year":"2002","journal-title":"Cancer Res"},{"key":"2019041122082637800_R234","first-page":"1653","article-title":"Ursodeoxycholic acid and F(6)-D(3) inhibit aberrant crypt proliferation in the rat azoxymethane model of colon cancer: roles of cyclin D1 and E-cadherin.","volume":"11","author":"Wali","year":"2002","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"2019041122082637800_R235","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1084\/jem.190.11.1583","article-title":"1\u03b1,25-Dihydroxyvitamin D3-induced myeloid cell differentiation is regulated by a vitamin D receptor-phosphatidylinositol 3-kinase signaling complex.","volume":"190","author":"Honma","year":"1999","journal-title":"J Exp Med"},{"key":"2019041122082637800_R236","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0145-2126(99)00143-5","article-title":"Myeloid and monocytoid leukemia cells have different sensitivity to differentiation-inducing activity of deoxyadenosine analogs.","volume":"24","author":"Niitsu","year":"2000","journal-title":"Leuk Res"},{"key":"2019041122082637800_R237","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0306-3623(98)00098-6","article-title":"Leukemia cell differentiation: cellular and molecular interactions of retinoids and vitamin D.","volume":"32","author":"James","year":"1999","journal-title":"Gen Pharmacol"},{"key":"2019041122082637800_R238","first-page":"198","article-title":"A novel uracil analog, 6-chloro-5-(2-propenyl)uracil, preferentially enhances growth inhibition and differentiation of myeloid leukemia cells induced by 1\u03b1,25-dihydroxyvitamin D3.","volume":"26","author":"Kanatani","year":"1998","journal-title":"Exp Hematol"},{"key":"2019041122082637800_R239","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1038\/sj.leu.2402614","article-title":"Combination of 22-oxa-1,25-dihydroxyvitamin D3, a vitamin D3 derivative, with vitamin K2 (VK2) synergistically enhances cell differentiation but suppresses VK2-inducing apoptosis in HL-60 cells.","volume":"16","author":"Funato","year":"2002","journal-title":"Leukemia"},{"key":"2019041122082637800_R240","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1128\/MCB.18.4.1911","article-title":"A differential screen for ligand-regulated genes: identification of HoxA10 as a target of vitamin D3 induction in myeloid leukemic cells.","volume":"18","author":"Rots","year":"1998","journal-title":"Mol Cell Biol"},{"key":"2019041122082637800_R241","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1002\/ajh.2830380112","article-title":"The effect of 1-hydroxyvitamin D3 for prolongation of leukemic transformation-free survival in myelodysplastic syndromes.","volume":"38","author":"Motomura","year":"1991","journal-title":"Am J Hematol"},{"key":"2019041122082637800_R242","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1046\/j.1365-2141.1998.00598.x","article-title":"Vitamin D treatment in myelodysplastic syndromes.","volume":"100","author":"Mellibovsky","year":"1998","journal-title":"Br J Haematol"},{"key":"2019041122082637800_R243","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1046\/j.1365-2141.1998.00881.x","article-title":"Differentiation therapy of myelodysplastic syndromes: fact of fiction?","volume":"102","author":"Santini","year":"1998","journal-title":"Br J Heamatol"},{"key":"2019041122082637800_R244","first-page":"83","article-title":"The independent and combined effects of RAR-, RXR-, and VDR-selective ligands on the growth of squamous cell carcinoma in vitro.","volume":"28","author":"Enepekides","year":"1999","journal-title":"J Otolaryngol"},{"key":"2019041122082637800_R245","first-page":"619","article-title":"Increased cdc2 and cdk2 kinase activity by retinoid X receptor \u03b3-mediated transcriptional down-regulation of the cyclin-dependent kinase inhibitor p21Cip1\/WAF1 correlates with terminal differentiation of squamous cell carcinoma lines.","volume":"9","author":"Crowe","year":"1998","journal-title":"Cell Growth Differ"},{"key":"2019041122082637800_R246","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1126\/science.280.5366.1069","article-title":"Inhibitory function of p21Cip1\/WAF1 in differentiation of primary mouse keratinocytes independent of cell cycle control.","volume":"280","author":"Di Cunto","year":"1998","journal-title":"Science"},{"key":"2019041122082637800_R247","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1210\/mend.16.6.0874","article-title":"Expression profiling in squamous carcinoma cells reveals pleiotropic effects of vitamin D3 analog EB1089 signaling on cell proliferation, differentiation, and immune system regulation.","volume":"16","author":"Lin","year":"2002","journal-title":"Mol Endocrinol"},{"key":"2019041122082637800_R248","doi-asserted-by":"crossref","first-page":"10399","DOI":"10.1073\/pnas.1630810100","article-title":"Kaposi\u2019s sarcoma-associated herpesvirus-infected primary effusion lymphoma has a plasma cell gene expression profile.","volume":"100","author":"Jenner","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"key":"2019041122082637800_R249","doi-asserted-by":"crossref","first-page":"3188","DOI":"10.1182\/blood.V96.9.3188","article-title":"Kaposi sarcoma is a therapeutic target for vitamin D(3) receptor agonist.","volume":"96","author":"Masood","year":"2000","journal-title":"Blood"},{"key":"2019041122082637800_R250","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1210\/edrv.20.3.0367","article-title":"Modulation of osteoclast differentiation and function by the new members of the tumor necrosis factor receptor and ligand families.","volume":"20","author":"Suda","year":"1999","journal-title":"Endocr Rev"},{"key":"2019041122082637800_R251","first-page":"54","article-title":"Calcitriol and its analog KH 1060 induce similar changes in keratinocyte cell cycle progression after topical application to mouse skin. A bromodeoxyuridine pulse-chase flow cytometric study.","volume":"1","author":"Lutzow-Holm","year":"1996","journal-title":"J Investig Dermatol Symp Proc"},{"key":"2019041122082637800_R252","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1042\/cs0980217","article-title":"Steroid hormone receptor expression and action in bone.","volume":"98","author":"Bland","year":"2000","journal-title":"Clin Sci (Lond)"},{"issue":"4 Suppl 1","key":"2019041122082637800_R253","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/0026-0495(90)90269-I","article-title":"Action of 1,25-dihydroxyvitamin D3 on calcium balance and bone turnover and its effect on vertebral fracture rate","volume":"39","author":"Gallagher","year":"1990","journal-title":"Metabolism"},{"key":"2019041122082637800_R254","doi-asserted-by":"crossref","first-page":"649","DOI":"10.7326\/0003-4819-113-9-649","article-title":"Treatment of postmenopausal osteoporosis with high doses of synthetic calcitriol. A randomized controlled study.","volume":"113","author":"Gallagher","year":"1990","journal-title":"Ann Intern Med"},{"key":"2019041122082637800_R255","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1056\/NEJM199202063260601","article-title":"Treatment of postmenopausal osteoporosis with calcitriol or calcium.","volume":"326","author":"Tilyard","year":"1992","journal-title":"N Engl J Med"},{"key":"2019041122082637800_R256","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/s002239900702","article-title":"Vitamin D therapy of osteoporosis: plain vitamin D therapy versus active vitamin D analog (D-hormone) therapy.","volume":"65","author":"Lau","year":"1999","journal-title":"Calcif Tissue Int"},{"key":"2019041122082637800_R257","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1007\/s002239900704","article-title":"The advantage of alfacalcidol over vitamin D in the treatment of osteoporosis.","volume":"65","author":"Shiraishi","year":"1999","journal-title":"Calcif Tissue Int"},{"key":"2019041122082637800_R258","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/S8756-3282(02)00682-8","article-title":"ED-71, a vitamin D analog, is a more potent inhibitor of bone resorption than alfacalcidol in an estrogen-deficient rat model of osteoporosis.","volume":"30","author":"Uchiyama","year":"2002","journal-title":"Bone"},{"key":"2019041122082637800_R259","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1002\/jbmr.5650110306","article-title":"Effects of a synthetic vitamin D analog, ED-71, on bone dynamics and strength in cancellous and cortical bone in prednisolone-treated rats.","volume":"11","author":"Tanaka","year":"1996","journal-title":"J Bone Miner Res"},{"key":"2019041122082637800_R260","doi-asserted-by":"crossref","first-page":"2517","DOI":"10.1016\/S0968-0896(98)80025-4","article-title":"Syntheses and preventive effects of analogues related to 1\u03b1,25-dihydroxy-2\u03b2-(3-hydroxypropoxy)vitamin D3 (ED-71) on bone mineral loss in ovariectomized rats.","volume":"6","author":"Ono","year":"1998","journal-title":"Bioorg Med Chem"},{"key":"2019041122082637800_R261","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1002\/jcb.10346","article-title":"A new active vitamin D analog, ED-71, causes increase in bone mass with preferential effects on bone in osteoporotic patients.","volume":"88","author":"Kubodera","year":"2003","journal-title":"J Cell Biochem"},{"key":"2019041122082637800_R262","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1210\/endo.143.5.8777","article-title":"Cellular and molecular events associated with the bone-protecting activity of the noncalcemic vitamin D analog Ro-26-9228 in osteopenic rats.","volume":"143","author":"Peleg","year":"2002","journal-title":"Endocrinology"},{"key":"2019041122082637800_R263","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1002\/jcb.10344","article-title":"Evidence for tissue- and cell-type selective activation of the vitamin D receptor by Ro-26-9228, a noncalcemic analog of vitamin D3.","volume":"88","author":"Peleg","year":"2003","journal-title":"J Cell Biochem"},{"key":"2019041122082637800_R264","doi-asserted-by":"crossref","first-page":"13487","DOI":"10.1073\/pnas.202471299","article-title":"A potent analog of 1\u03b1,25-dihydroxyvitamin D3 selectively induces bone formation.","volume":"99","author":"Shevde","year":"2002","journal-title":"Proc Natl Acad Sci USA"},{"key":"2019041122082637800_R265","doi-asserted-by":"crossref","first-page":"31756","DOI":"10.1074\/jbc.M304737200","article-title":"2-Methylene-19-nor-(20S)-1,25-dihydroxyvitamin D3 potently stimulates gene-specific DNA binding of the vitamin D receptor in osteoblasts.","volume":"278","author":"Yamamoto","year":"2003","journal-title":"J Biol Chem"},{"key":"2019041122082637800_R266","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1172\/JCI0215219","article-title":"1,25-Dihydroxyvitamin D3 is a negative endocrine regulator of the renin-angiotensin system.","volume":"110","author":"Li","year":"2002","journal-title":"J Clin Invest"},{"key":"2019041122082637800_R267","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1093\/protein\/8.2.127","article-title":"LIGPLOT: a program to generate schematic diagrams of protein-ligand interactions.","volume":"8","author":"Wallace","year":"1995","journal-title":"Protein Eng"},{"key":"2019041122082637800_R268","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1006\/jmbi.1994.1334","article-title":"Satisfying hydrogen bonding potential in proteins.","volume":"238","author":"McDonald","year":"1994","journal-title":"J Mol Biol"},{"key":"2019041122082637800_R269","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1038\/sj.bjc.6601104","article-title":"A phase II study of the vitamin D analogue seocalcitol in patients with inoperable hepatocellular carcinoma.","volume":"89","author":"Dalhoff","year":"2003","journal-title":"Br J Cancer"},{"key":"2019041122082637800_R270","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1111\/j.1365-2133.1996.tb07945.x","article-title":"Safety and efficacy of oral calcitriol (1,25-dihydroxyvitamin D3) for the treatment of psoriasis.","volume":"134","author":"Perez","year":"1996","journal-title":"Br J Dermatol"},{"key":"2019041122082637800_R271","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1046\/j.1365-2133.2002.04567.x","article-title":"Long-term efficacy and safety of tacalcitol ointment in patients with chronic plaque psoriasis.","volume":"146","author":"van de Kerkhof","year":"2002","journal-title":"Br J Dermatol"},{"key":"2019041122082637800_R272","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1046\/j.1365-2133.1999.02975.x","article-title":"Topical maxacalcitol for the treatment of psoriasis vulgaris: a placebo-controlled, double-blind, dose-finding study with active comparator.","volume":"141","author":"Barker","year":"1999","journal-title":"Br J Dermatol"},{"key":"2019041122082637800_R273","first-page":"221","author":"Vickery","year":"2000","journal-title":"New tissue-selective vitamin D receptor modulators (VDRMs)"},{"key":"2019041122082637800_R274","doi-asserted-by":"crossref","first-page":"S48","DOI":"10.1053\/ajkd.1998.v32.pm9808143","article-title":"Suppression of parathyroid hormone secretion in hemodialysis patients by a novel vitamin D analogue: 19-nor-1,25-dihydroxyvitamin D2","volume":"32","author":"Llach","year":"1998","journal-title":"Am J Kidney Dis"},{"issue":"Suppl 10","key":"2019041122082637800_R275","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1093\/ndt\/17.suppl_10.28","article-title":"Long-term effect of 1,25-dihydroxy-22-oxavitamin D(3) on secondary hyperparathyroidism in haemodialysis patients","volume":"17","author":"Akizawa","year":"2002","journal-title":"One-year administration study. Nephrol Dial Transplant"},{"key":"2019041122082637800_R276","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1126\/science.270.5240.1354","article-title":"Sequence and characterization of a coactivator for the steroid hormone receptor superfamily.","volume":"270","author":"Onate","year":"1995","journal-title":"Science"},{"key":"2019041122082637800_R277","doi-asserted-by":"crossref","first-page":"2735","DOI":"10.1128\/MCB.17.5.2735","article-title":"GRIP1, a transcriptional coactivator for the AF-2 transactivation domain of steroid, thyroid, retinoid, and vitamin D receptors.","volume":"17","author":"Hong","year":"1997","journal-title":"Mol Cell Biol"},{"key":"2019041122082637800_R278","doi-asserted-by":"crossref","first-page":"8479","DOI":"10.1073\/pnas.94.16.8479","article-title":"RAC3, a steroid\/nuclear receptor-associated coactivator that is related to SRC-1 and TIF2.","volume":"94","author":"Li","year":"1997","journal-title":"Proc Natl Acad Sci USA"},{"key":"2019041122082637800_R279","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1038\/42652","article-title":"The transcriptional coactivator p\/CIP binds CBP and mediates nuclear receptor function.","volume":"387","author":"Torchia","year":"1997","journal-title":"Nature"},{"key":"2019041122082637800_R280","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1210\/mend.11.10.9990","article-title":"Evidence for ligand-dependent intramolecular folding of the AF-2 domain in vitamin D receptor-activated transcription and coactivator interaction.","volume":"11","author":"Masuyama","year":"1997","journal-title":"Mol Endocrinol"},{"key":"2019041122082637800_R281","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1002\/j.1460-2075.1996.tb00339.x","article-title":"Differential ligand-dependent interactions between the AF-2 activating domain of nuclear receptors and the putative transcriptional intermediary factors mSUG1 and TIF1.","volume":"15","author":"vom Baur","year":"1996","journal-title":"EMBO J"},{"key":"2019041122082637800_R282","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1006\/bbrc.1998.9799","article-title":"The interaction of the vitamin D receptor with nuclear receptor corepressors and coactivators.","volume":"253","author":"Tagami","year":"1998","journal-title":"Biochem Biophys Res Commun"},{"key":"2019041122082637800_R283","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S1074-5521(99)80072-6","article-title":"Novel nonsecosteroidal vitamin D mimics exert VDR-modulating activities with less calcium mobilization than 1,25-dihydroxyvitamin D3.","volume":"6","author":"Boehm","year":"1999","journal-title":"Chem Biol"},{"key":"2019041122082637800_R284","first-page":"60","article-title":"Toxicity of 1,25-dihydroxyvitamin D3, tacalcitol, and calcipotriol after topical treatment in rats.","volume":"1","author":"Mortensen","year":"1996","journal-title":"J Investig Dermatol Symp Proc"}],"container-title":["Endocrine Reviews"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/edrv\/article-pdf\/26\/5\/662\/8861799\/edrv0662.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,3]],"date-time":"2023-05-03T22:00:03Z","timestamp":1683151203000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/edrv\/article\/26\/5\/662\/2355188"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,3,29]]},"references-count":284,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2005,3,29]]},"published-print":{"date-parts":[[2005,8,1]]}},"URL":"https:\/\/doi.org\/10.1210\/er.2004-0002","relation":{},"ISSN":["0163-769X","1945-7189"],"issn-type":[{"value":"0163-769X","type":"print"},{"value":"1945-7189","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,3,29]]}}}